Chapter 32: Influenza

Chapter 32. Influenza

Adamantanes have activity against which influenza types?

a. Influenza A

b. Influenza B

c. Influenza C

d. Haemophilus influenzae

Answer a is correct. Adamantanes (rimantadine and amantadine) have activity against influenza A, however, over the past few influenza seasons, resistance to the adamantanes has significantly increased.

Answer b is incorrect. Adamantanes do not have activity against influenza B.

Answer c is incorrect. Influenza C is not a common cause in influenza infections.

Answer d is incorrect. Haemophilus influenzae is a gram-negative bacterial organism that causes upper respiratory tract infections.

Which of the following patient(s) should receive influenza vaccination? Select all that apply.

a. CH who is 8-year-old boy with a history of cystic fibrosis.

b. GS who is a healthy 10-month-old baby girl.

c. KL who is a 48-year-old man with diabetes.

d. RC who is a healthy 65-year-old woman.

Answer a is correct. Chronic pulmonary patients are at a higher risk of having influenza and influenza-related complications. He should receive influenza vaccination with inactivated influenza vaccine (IIV). He would not be a candidate for live-attenuated influenza vaccine (LAIV) because he has cystic fibrosis or recombinant vaccine (RIV) because of his age.

Answer b is correct. Children between ages 6 and 59 months are at a higher risk of having influenza and influenza-related complications. She should receive influenza vaccination with IIV. She would not be a candidate for LAIV or RIV because of her age.

Answer c is correct. Diabetic patients are at a higher risk of having influenza and influenza-related complications. He should receive influenza vaccination with IIV or RIV. He would not be a candidate for LAIV because he has diabetes.

Answer d is correct. All persons of age 50 or older are at a higher risk of having influenza and influenza-related complications. She should receive influenza vaccination with IIV or RIV. She would not be a candidate for LAIV since she is older than 49 years.

Select the agent that is administered via intramuscular injection for influenza prevention or postexposure prophylaxis.

a. Inactivated influenza vaccine (IIV)

b. Live-attenuated influenza vaccine (LAIV)

c. Zanamivir

d. Amantadine

Answer a is correct....